Biomemory
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Biomemory?
Biomemory is currently owned by Aloe Private Equity through Sorbonne Venture (2022 vintage), since 2024. Across its history, Biomemory has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Aloe Private EquitySorbonne Venture · 2022 · VC
4 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Key takeaways
- ·Co-held by Crédit Mutuel Equity, Crédit Mutuel Innovation, Aloe Private Equity and Audacia since 2024.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Crédit Mutuel Equity, Crédit Mutuel Innovation, Aloe Private Equity and Audacia since 2024.
Co-invest · 4 holders · 2024 · present
Crédit Mutuel EquityActive
2024 · present(2yr) · Crédit Mutuel Equity · 1992 · Growth
Aloe Private EquityActive
2024 · present(2yr) · Sorbonne Venture · 2022 · VC
Crédit Mutuel InnovationActive
2024 · present(2yr) · Crédit Mutuel Innovation Evergreen Capital · 2004 · Evergreen
AudaciaActive
2025 · present(1yr) · Sorbonne Venture by Audacia · 2020 · VC
More from Sorbonne Venture
Other portfolio companies in the same fund.
More PE-backed in TMT
Comparable tmt deals from other GPs.
US
Norway
BelgiumTrack Biomemory
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Biomemory?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Biomemory.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue